N115 Non-Steroidal COPD/Pulmonary Fibrosis Nasal Spray

Email
No image set
Notify Me
Manufacturer: EmphyCorp
Description
  • Patented Rx Technology (6 Drug Patents)
  • Drug Free, Non-Steroidal COPD/Pulmonary Fibrosis Nasal Spray that has shown to relieve clinical symptoms and improve lung functions, decrease coughing, and improve FEV-1, FVC, SaO2, and increase FEV-1/FVC ratios from 52% to 86% in all patients with Idiopathic Pulmonary Fibrosis (IPF).  
  • Completed US Phase I, Phase II, Phase III Clinical Trials for COPD Pulmonary Fibrosis/Interstitial Lung Disease.
  • Submitted NDA to the FDA defining Medical Endpoint for the NDA Marketing Application.
  • Received US FDA Orphan Drug Designation in 2005 for Cystic Fibrosis and Interstitial Lung Disease

Our Products

Please see "Our Products" Tab on the Home Page